341 related articles for article (PubMed ID: 25502483)
1. A systematic review of aspirin in primary prevention: is it time for a new approach?
Brotons C; Benamouzig R; Filipiak KJ; Limmroth V; Borghi C
Am J Cardiovasc Drugs; 2015 Apr; 15(2):113-33. PubMed ID: 25502483
[TBL] [Abstract][Full Text] [Related]
2. Aspirin for primary prevention: yes or no?
Selak V; Elley CR; Wells S; Rodgers A; Sharpe N
J Prim Health Care; 2010 Jun; 2(2):92-9. PubMed ID: 20690297
[TBL] [Abstract][Full Text] [Related]
3. Investigating the effectiveness of different aspirin dosing regimens and the timing of aspirin intake in primary and secondary prevention of cardiovascular disease: protocol for a systematic review.
Bem D; Dretzke J; Stevens S; Lordkipanidzé M; Hodgkinson J; Bayliss S; Moore D; Fitzmaurice D
Syst Rev; 2015 Jun; 4():88. PubMed ID: 26088608
[TBL] [Abstract][Full Text] [Related]
4. Recent Evidence Examining Efficacy and Safety of Aspirin for Primary Cardiovascular Disease Prevention.
Carson E; Hemenway AN
Ann Pharmacother; 2019 Jul; 53(7):738-745. PubMed ID: 30654618
[TBL] [Abstract][Full Text] [Related]
5. Aspirin for primary prevention of cardiovascular disease events.
Nemerovski CW; Salinitri FD; Morbitzer KA; Moser LR
Pharmacotherapy; 2012 Nov; 32(11):1020-35. PubMed ID: 23019080
[TBL] [Abstract][Full Text] [Related]
6. Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services Task Force.
Chubak J; Whitlock EP; Williams SB; Kamineni A; Burda BU; Buist DS; Anderson ML
Ann Intern Med; 2016 Jun; 164(12):814-25. PubMed ID: 27064482
[TBL] [Abstract][Full Text] [Related]
7. A review and study of aspirin utilization for the primary prevention of cardiovascular events in a psychiatric population.
Victor K; Skelly M; Mulcahy K; Demler TL; Trigoboff E
Int Clin Psychopharmacol; 2018 Sep; 33(5):274-281. PubMed ID: 29939889
[TBL] [Abstract][Full Text] [Related]
8. Aspirin for primary prevention of cardiovascular disease: is it time to move on?
Knickelbine T; Miedema MD
Curr Opin Cardiol; 2019 Sep; 34(5):510-513. PubMed ID: 31219876
[TBL] [Abstract][Full Text] [Related]
9. A polypill for all? Critical review of the polypill literature for primary prevention of cardiovascular disease and stroke.
Carey KM; Comee MR; Donovan JL; Kanaan AO
Ann Pharmacother; 2012 May; 46(5):688-95. PubMed ID: 22570437
[TBL] [Abstract][Full Text] [Related]
10. Which Aspirin Dose and Preparation Is Best for the Long-Term Prevention of Cardiovascular Disease and Cancer? Evidence From a Systematic Review and Network Meta-Analysis.
Lotrionte M; Biasucci LM; Peruzzi M; Frati G; Giordano A; Biondi-Zoccai G
Prog Cardiovasc Dis; 2016; 58(5):495-504. PubMed ID: 26851562
[TBL] [Abstract][Full Text] [Related]
11. Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women.
van Kruijsdijk RC; Visseren FL; Ridker PM; Dorresteijn JA; Buring JE; van der Graaf Y; Cook NR
Heart; 2015 Mar; 101(5):369-76. PubMed ID: 25475110
[TBL] [Abstract][Full Text] [Related]
12. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: Benefit or risk?
Leggio M; Bendini MG; Caldarone E; Lombardi M; Severi P; D'Emidio S; Stavri DC; Armeni M; Bravi V; Mazza A
Diabetes Metab; 2018 Jun; 44(3):217-225. PubMed ID: 29257747
[TBL] [Abstract][Full Text] [Related]
13. Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the U.S. Preventive Services Task Force.
Whitlock EP; Burda BU; Williams SB; Guirguis-Blake JM; Evans CV
Ann Intern Med; 2016 Jun; 164(12):826-35. PubMed ID: 27064261
[TBL] [Abstract][Full Text] [Related]
14. Which patients should receive aspirin for primary prevention of cardiovascular disease? An economic evaluation.
Annemans L; Lamotte M; Kubin M; Evers T; Verheugt FW
Int J Clin Pract; 2006 Sep; 60(9):1129-37. PubMed ID: 16939558
[TBL] [Abstract][Full Text] [Related]
15. Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease: Advances in Diagnosis and Treatment.
Mora S; Manson JE
JAMA Intern Med; 2016 Aug; 176(8):1195-204. PubMed ID: 27322595
[TBL] [Abstract][Full Text] [Related]
16. Is There Still a Role for Aspirin in Primary Prevention in Women in 2020?
Sulaica EM; Asias-Dinh BD; Wanat MA; Birtcher KK
Curr Atheroscler Rep; 2020 Jun; 22(8):34. PubMed ID: 32556683
[TBL] [Abstract][Full Text] [Related]
17. [Primary prevention of cardiovascular diseases with acetylsalicylic acid].
Waltering A; Hemkens L; Florack C
Dtsch Med Wochenschr; 2005 Dec; 130(49):2847-52. PubMed ID: 16317615
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]